Insmed Incorporated
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
Stock Snapshot
As of today, Insmed Incorporated(INSM) shares are valued at $143.62. The company's market cap stands at 30.82B, with a P/E ratio of -22.92.
On 2026-04-16, Insmed Incorporated(INSM) stock moved within a range of $142.06 to $146.43. With shares now at $143.62, the stock is trading +1.1% above its intraday low and -1.9% below the session's peak.
Trading volume for Insmed Incorporated(INSM) stock has reached 2.16M, versus its average volume of 2.02M.
The stock's 52-week range extends from a low of $63.81 to a high of $212.75.
The stock's 52-week range extends from a low of $63.81 to a high of $212.75.
INSM News
Guggenheim raised the firm’s price target on Insmed (INSM) to $230 from $227 and keeps a Buy rating on the shares. The firm adjusted estimates as part of a Q1 e...
Stanley Druckenmiller Made 1 Huge Bet That Still Looks Attractive Today and Cut 2 Top Positions By Thomas Richmond Published Apr 13, 2:36PM EDT Quick Read Sta...
Analyst ratings
100%
of 22 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.